Literature DB >> 20667285

A review of the current guidelines for depression treatment.

Alan J Gelenberg1.   

Abstract

A variety of American and European guidelines are available for clinicians treating major depressive disorder and depressive subtypes. Major Western guidelines published since 2000 make similar recommendations for all stages of treatment for depression, including a reliance on measurement-based care. First-line treatment is usually a serotonin reuptake inhibitor, psychotherapy, or a combination of pharmacotherapy and psychotherapy. Next-step treatment recommendations are switching or augmentation, depending on patient response to the initial treatment. Maintenance therapy continues the approach that led to remission. The American Psychiatric Association will release a new treatment guideline to offer information on developments made since the last guidelines were published in 2000. Despite progress made during the last decade, no major breakthroughs in the treatment of depression have occurred, and genetic testing developments allowing for personalized care remain the goal of research. (c) Copyright 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20667285     DOI: 10.4088/JCP.9078tx1c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  24 in total

1.  Timosaponin derivative YY-23 acts as a non-competitive NMDA receptor antagonist and exerts a rapid antidepressant-like effect in mice.

Authors:  Qi Zhang; Fei Guo; Zhi-wen Fu; Bing Zhang; Cheng-gang Huang; Yang Li
Journal:  Acta Pharmacol Sin       Date:  2015-12-21       Impact factor: 6.150

2.  Matter over mind: How mental health symptom presentations shape diagnostic outcomes.

Authors:  Alexandra Tate
Journal:  Health (London)       Date:  2019-04-03

3.  Pharmacogenetics of glutamate system genes and SSRI-associated sexual dysfunction.

Authors:  Jeffrey R Bishop; Sharon S Chae; Shitalben Patel; Jessica Moline; Vicki L Ellingrod
Journal:  Psychiatry Res       Date:  2012-04-24       Impact factor: 3.222

4.  The latent structure and comorbidity patterns of generalized anxiety disorder and major depressive disorder: a national study.

Authors:  Carlos Blanco; José M Rubio; Melanie Wall; Roberto Secades-Villa; Katja Beesdo-Baum; Shuai Wang
Journal:  Depress Anxiety       Date:  2013-06-14       Impact factor: 6.505

5.  The neuroprotective and antidepressant-like effects of Hcyb1, a novel selective PDE2 inhibitor.

Authors:  Li Liu; Jing Zheng; Xian-Feng Huang; Xia Zhu; Shu-Ming Ding; Heng-Ming Ke; James M O'Donnell; Han-Ting Zhang; Guo-Qiang Song; Ying Xu
Journal:  CNS Neurosci Ther       Date:  2018-04-27       Impact factor: 5.243

6.  Predictors of primary care management of depression in the Veterans Affairs healthcare system.

Authors:  Evelyn T Chang; Jennifer L Magnabosco; Edmund Chaney; Andrew Lanto; Barbara Simon; Elizabeth M Yano; Lisa V Rubenstein
Journal:  J Gen Intern Med       Date:  2014-02-25       Impact factor: 5.128

7.  Antisocial behavioral syndromes and 3-year quality-of-life outcomes in United States adults.

Authors:  R B Goldstein; D A Dawson; S M Smith; B F Grant
Journal:  Acta Psychiatr Scand       Date:  2012-02-29       Impact factor: 6.392

8.  Self-report and clinician-rated measures of depression severity: can one replace the other?

Authors:  Rudolf Uher; Roy H Perlis; Anna Placentino; Mojca Zvezdana Dernovšek; Neven Henigsberg; Ole Mors; Wolfgang Maier; Peter McGuffin; Anne Farmer
Journal:  Depress Anxiety       Date:  2012-08-29       Impact factor: 6.505

9.  Baseline difference between patients' and clinicians' rated illness severity scores and subsequent outcomes in major depressive disorder: analysis of the sequenced treatment alternatives to relieve depression data.

Authors:  Mitsuhiro Tada; Hiroyuki Uchida; Takefumi Suzuki; Takayuki Abe; Bruce G Pollock; Masaru Mimura
Journal:  J Clin Psychopharmacol       Date:  2014-06       Impact factor: 3.153

10.  The Epidemiology of Antisocial Behavioral Syndromes in Adulthood: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Risë B Goldstein; S Patricia Chou; Tulshi D Saha; Sharon M Smith; Jeesun Jung; Haitao Zhang; Roger P Pickering; W June Ruan; Boji Huang; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2017-01       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.